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and EF at one year between the two groups. The results are expressed as mean d SD. 
Results: Df the 968 patients randomised, 972 (96.4%) were alive at one year. In the sur- 
viving patients 764 (79%) had available WMSI calculations and 51.5 (53%) had EF mea- 
sured at one year. The WMSI in the CABG group (n=363) was 1.3 f 0.4, compared with 
1.2 * 0.4 in PCI group (n=361), (PcO.46, t-test). The EF in the CABG group (n=245) was 
54.6 f 9.6, compared with 55.3 f 9.3 in PCI group (n=270), difference = 0.5, 95% Cl -1 .I 
to 2.1, (P=O.55. t-test). Compared with the pre procedural values both groups showed a 
similar change in WMSI and EF. The WMSI was greater at 12 months: CABG group 1 .19 
versus 1.27, (mean difference 0.08, 95% Cl 0.04 to 0.11, pcO.001, Wilcoxon signed rank 
test), PCI group 1.19 versus 1.26 (mean difference 0.07, 95% Cl 0.03 to 0.10, p=O.OOl). 
EF was lower in both groups: CABG group 57.5 versus 54.9, (mean difference -2.7, 95% 
Cl -4.0 to -1.4, pcO.001, Wilcoxon signed rank test), in the PCI group 56.7 versus 54.9 
(mean difference -1.9, 95% Cl -2.9 to -0.6. p=O.OOl). 
Conclusions: No difference was observed in the Stent or Surgery study at one year, in LV 
function in patients treated with PCI or CABG. At one year there has been a minor 
decline in global and regional function which may be attributable to the occurrence of fac- 
tors which affect the cardiac function. 
1076-l 85 Final Angiographic and Clinical Results of the Latin 
America Small Vessel Randomized Study (LASMAL 
Trial) 
Alfred0 E. Rodriguez Msximo J. Rodriguez Alemparte, Carlos Fernandez Pereira, 
Alberlo Samoaolesi. Ronald0 Loures Buena. Carlos Rubio. Cesar F. Viao. Angel 
Obregon S&o& on behalf of Biodivysio Investigators, Otsmendi Hospital; Bu&os Aires, 
Argentina, Adrogue Medical Institute, Buenos Aires, Argentina 
BACKGROUND: Glycoprotein llbillla receptor inhibitors (GPI) reduce peri-procedural 
ischemic events in pts undergoing PCI. The optimal timing of blood draw(s) to detect CK- 
MB elevations after PCI is not well established, and less is known about their clinical pre- 
dictors. METHODS: In the TARGET trial, 4609 patients undergoing PCI were random- 
ized to abcixlmab vs tirofiban. CK-MB values were determined every 6 hrs. Timing of MB 
elevations, correlation with symptoms, and its predictors were evaluated from 4329 pts. 
RESULTS: Enzymatic infarcts (Ml, single MB value 23X or a 50% rise above abnormal 
baseline) were seen in 5.9% of pts, of whom 93.9% were reportedly asymptomatic. Only 
1.0% of pts had Q-wave infarctions after PCI, of whom l/4 had peri-PCI symptoms. In 
contrast, 67% of pts with reported symptoms after PCI had enzymatic or Q-wave infarcts. 
Table shows detection rates of Ml at each time point. In a logistic regression model, 
acute coronary syndrome (ACS). heparin use, and increasing age. but not diabetes, 
were independent predictors of peri-PCI Ml. Pre-PCI clopidogrel use was an independent 
predictor for lower rates of Ml (OR=0.57, CL [0.36-0.651). CONCLUSIONS: In pts under- 
going PCI, using GPI and contemporary stems, at least 3 blood samples within 24 hours 
are required for optimal detection of most Ml. An 16-hr sample has the best detection 
rate as a single time point. While ACS is associated with high risk of MI. pre-PCI clopi- 
dogrel therapy may have a significant cardioprotective effect in limiting CK-MB rise. 
Background: There were a conflictive data about the role of stems preventing restenosis 
in small coronary arteries. 
Methods: Between March lo December 2001,246 patients with severe stenosis in small 
native coronary artery (~2.9 mm) and clinical indication of myocardial revascularization 
were randomized in 15 centers of Latinamerica, 124 were randomized to stent and 122 
to PTCA In order to validate the reference diameter (RD) of the vessel , a comparative 
analysis between quantitative coronary angiography @CA) and Intravascular Ultrasound 
was perform. The end point of the study was lo compare angiographic binary restenosis, 
minimal luminal diameter (MLD). net gain, target vessel revascularization (TVR) and 
freedom from maior adverse cardiovascular events (MACE) at six months of follow UP, 
In conclusion: The results of the PIXEL study will help lo determine the role of direct 
stenting in small vessels. This knowledge might prove to be of great interest in the forth- 
coming era of drug eluting stents. 
1076-l 87 Timing and Risk Factors for Enzymatic Myocardial 
Infarctions in Patients Undergoing Percutaneous 
Intervention: Insights From TARGET 
H. Mehrdad Sadeahi, Cindy L. Grines, David J. Molitemo, Jennifer White. Howard 
Herrmann, Eric A. Powers, David J. Cohen, Michel E. Bertrand, Franz-Josef Neumann, 
Peter M. DiBattiste, Gregg W. Stone, Eric J. Topol, William Beaumont Hospital, Royal 
Oak, MI, The Cleveland Clinic Foundation. Cleveland, OH 
Timing of MB elevations 
6-hr 12-hr 16-hr 24.hr add’1 sample 
between both re&cularization strategies. 
Results: Both groups had similar clinical demographics and angiographic characteris- CK-MB>3X 5.6% 23.5% 47.0% 16.9% 4.6% 
tics. 
After randomization in the PTCA group. 16% crossed over to stents during the initial pro- 
cedure. Intravascular Ultrasound showed a RD in stent and PTCA of 2.6 and 2.76 mm 
respectively (ns). At 30 days patients in stent arm had less incidence of MACE than 
those included in PTCA (2.4% vs 9.6% respectively p=O.O45) Six months follow up 
anglogram was obtained in 91% of patients. 
Six months QCA and Clinical Data PTCA (122 ) Stent (124) p 
RD (mm) 2.47 +0.23 2.5 i 0.20 0.246 
MLD Post (mm) 2.1 io.30 2.32 0.25 0.0002 
MLD Follow up(mm) 1.53 2 0.67 1.76 + 0.67 0.013 
Net Gain (mm) 0.61 + 0.69 1.11 ?; 0.66 0.002 
Restenosis (%) 29 19 0.118 
TVR (%) 16 14.5 0.568 
MACE (“‘0) 27 16.9 0.078 
Conclusions: An initial strategy with stems at long term follow up achieved better MLD 
and net gain than those initially treated with PTCA. Angiographic restenosis and MACE 
showed a trend to be low with stent therapy. 
1076-l 86 Results of the PIXEL Study: Randomized Multlcenter 
Trial Comparing Direct and Conventional Predilation 
Stenting in Small Vessels 
1076-188 Acute and Late Outcome After Directional Coronary 
Atherectomy Plus Stenting Versus Stenting Alone in 
True Bifurcation Lesions 
Alaide Chisffo, Francesco Liistro, Goran Stankovic, Flavio Airoldi, MaIteo Montorfano, 
Carlo Di Mario, Davide Tavano, Antonio Colombo, San Raffaele Hospital, Milan, Italy, 
EM0 Centro Cuore Columbus Hospital. Milan, Italy 
Background: The aim of this study was to assess acute and late outcome following 
treatment of true bifurcation lesions with Directional Coronary Atherectomy (DCA) plus 
stenting (DCA group) compared to stem alone (Stent group). Methods and Results 68 
lesions in DCA group and 332 lesions in Stent group were analyzed. Baseline clinical 
and angiographic characteristics were well matched. Reference diameters in main 
branch (MB) and side branch (SB) were similar in two groups (3.1+0.5 vs. 3.020.5 and 
2.4+0.5 vs. 2.4t0.5, p=NS). Bigger minimal lumen diameter (MLD) post-procedure and 
at follow-up was achieved in DCA group (table). Binary restenosis rate (MB 17% vs 34%, 
p=O.O6 and SB 23.5% vs 41%, p=O.O9) was lower in DCA group. There was no differ- 
ence in rate of in-hospital major adverse cardiac events (MACE, i.e. death, non-Q and Q- 
wave myocardial infarction (Ml), need of revascularization) between two groups (9% 
vs.9.6%; p=NS). At 20+16 months f-up MACE rate was lower in DCA group 
(13.6%vs.32.2%; p=rJ.O2). In DCA group there were no deaths, Ml or CABG and in Stent 
group 4 pts died, 7 had Ml and 3 underwent CABG. Repeat PTCA rate was similar 
(13.6% vs. 24.8%, p=NS). Conclusions: DCA plus stenting in bifurcation lesions is not 
associated with an increased incidence of in-hospital MACE and results in improved clin- 
ical and angiographic outcome. 
Euloaio Garcia Antonio Machado, Javier Goicolea, Christian Homsy. On behalf of the 
PIXEL study investigators. Hospital Gregorio Maranon, Madrid, Spain 
Background: Coronary stenting has been established the preferred form of percutane- 
ovs revascularizarion in vessels 2 3.0 mm in diameter, accounting for more than 60% of 
the procedures, half of those performed without prior balloon pro-dilation. Trials trying to 
establish the role of stenting in small vessels have offered contradictory results and feasi- 
bility and safety of direct stenting in < 3.0 mm vessels has not been tested. 
Variables DCA Stent P value 
MB MLD After procedure 3.19+0.56 2.91+ 0.57 0.006 
MB MLD follow-up 2.0+ 1.1 i .6* 0.8 0.05 
MB Late loss 0.90t 1.2 i 23 0.8 0.1 
SB MLD After procedure 2.2+ 0.5 2.01* 0.7 0.2 
Objective and design of the study: The primary objective of the study is to demon- SB MLD follow-up 1.4* 0.7 1.2* 0.7 0.1 
strate the medium term efficacy of a no pre-dilatation strategy for elective stent implanta- SB Late loss 0.6* 0.6 o.az 0.7 0.4 
tion in native coronary arteries t 2.2mm and ~2.7 mm in diameter by on line QCA. The 
study is a prospective, randomized trial of 350 patients recruited by 26 hospitals from 
Europe, South America, India and New Zealand. The stent used was specially designed 1076-189 - 
Clinical and Angiographic Effects of Directional 
for small vessels ( Pixel stent ).The patients were centrally randomized 1:l to stent Atherectomy In De Novo Coronary Artery Lesions 
implantation with and without pre-dilation. Enrollment started in June 2001 and was corn- Located at the Ostium of the Left Anterior Descending 
pleted in August 2002. Mean patient age was 64 years; 176 patients were randomized to Artery 
pre-dilation and 174 to direct stenting. 
Endpoints: The primary endpoint is procedure success in the no pre-dilation group : Flavio Airoldi, Carlo Di Mario, Carlo Briguon’, Goran Stankovic, Alaide Chieffo, Maneo 
attainment of final result of ~30% in stent residual stenosis in the absence of MACE at 30 
Montorfano, Davide Tavano. Antonio Colombo, San Raffaele Hospital. Milan, Italy. Emo 
days. Secondary endpoints include : Acute success, procedural and fluoro time; Angio- Centro Cuore Columbus, Milan, Italy 
graphic restenosis , target site rsvascularization and target vessel failure at 6 months; Lesions located at the ostium of the left descending anterior artery (LAD) sre considered 
MACE at 6 months. Clinical and angiographic data post procedure and at follow up will an ideal target for directional atherectomy (DCA). Methods: we did a matched compari- 
be evaluated by independent corelabs. son of the immediate and mid term results of a series of 117 consecutive patients with 
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de-nova lesions located at the ostium of the LAD that underwent DCA before stenting 
(DCA+S) in 46 cases or that were treated with stenting alone (S) in 71 cases. Results: 
Techmcal success in DCA+S and S group was 95.6% and 95.7%, respectively, p=O.69. 
No differences were observed in in-hospital major adverse events (MACE, i.e. death, 
non-Q and Q-wave myocardial infarction, need of revascularization) (4.3 % for DCA+S 
and 4.2% for S respectively, p=n.s). Angiographic results are summarized in table. All 
patients had &months clinical follow-up: MACE rate was lower (even though not signifi- 
catively) in DCA+S group than in S group, (20.0% vs. 35.5%, p=O.O61). The angiographic 
follow-up was performed for 95 patients after 5.9e2.2 months and showed a significantly 
lower binary restenosis rate for DCA+S group in comparison to S group (10.8% vs. 
33.3%, p=O.O15). Conclusions: DCA before stenting in de-now ostial LAD lesions is safe 
and is associated to a high rate of technical success. Follow-up data indicate that DCA+S 
in this setting provides a significantly larger MLD and lowers the incidence of restenosis if 
compared to stenting alone. 
* = p<O.OS for compansons between the two groups (independent samples t-test) 
Basal ref, mm, Basal MLD, 
n=ll7 mm, n=ll7 
CCA 3.4tO.5 1.1&S 
+S 
Acute Gain, 
mm, n=ll7 
2.4ztO.6 
Late loss, 
mm, n=95 
0.6a0.6 
Loss index, 
n=95 
0.33*0.35* 
S 3.4a0.4 1.2+0.5 2.1*0.7 1.0+0.7 0.59*0.42 
1076-l 90 Unprotected Left Main Coronary Stenting: Predictors of 
Restenosie and Long-Term Follow-Up Results 
Samin K. Sharma, Annapoorna S. Kini, Cristina A. Mitre, Michael C. Kim, Mazullah 
Kamran, Jonathan D. Marmur, The Mount Sinai Medical Center, New York, NY 
Background: Studies have reported excellent short and mid-term outcome of unpro- 
tected left main coronary artery (ULMCA) stenting with only 8.15% clinical restenosis 
rate. The predictors of restenosis after ULMCA stenting especially in high surgical risk 
patients have not been well established. 
Methods: We present the complete follow-up results in 188 consecutive patients under- 
going ULMCA stenting at our center from January 1998 to June 2002. Based on Parson- 
net surgical risk score. patients were divided into high surgical risk (n=ll2) with a score 
~15 and low surgical risk (n=76) for <I5 score. 
Results: All patients underwent stenting, 65% after rotablatlon, and procedure was suc- 
cessful in all with one in-hospital death due to CVA. Mean age was 82i6 yrs, mean LVEF 
31*14%, GP inhibitors use 76%. and elective IABP in 38%. Stenosis location: ostium in 
25%, body/distal in 60%, and bifurcation in 15%. CK-MB elevation occurred in 21%, with 
z-5x normal in 4%. Vascular complications occurred in 3%. All but one patients were dis- 
charged alive at a mean duration of 5*4 days. At a mean one-year follow-up there were 
16 deaths: 8 cardiac (4 Cl-IF, 2 MI, 1 arrhythmia, 1 stent thrombosis), 8 non-cardiac (4 
CVA, 2 pneumonia, 1 hyperkaliemia, 1 neoplasm). A total of 26 patients (15%) required 
repeat intaivention for recurrence of angina. heart failure, or Dositive non-invasive test- 
p=O.OOOl for PCI YS CABG respectively. 
Conclusions: The immediate and medium term survival followng unprotected LMCA 
stenting was equivalent to CABG. The longer term outcome of PCI was limited by the 
need for TLR. Stenting offers an excellent alternative to CABG in patients with relative 
contraindications to surgery. 
1076-l 92 Clinical Outcome After Multivessel Stenting in Diabetic 
Versus Nondiabetic Patients: Impact of Restenosis and 
Disease Progression 
Mohamed Loutfi Emmanuel Salengro, Marco Boccalatte, Bruno Farah, Jean Fajadet, 
Jean Marco, Clinique Pasteur UCI, Toulouse, France 
BackgrounctDiabetes Mellitus has a negative impact on outcome after percutaneous 
interventions (PCI). We examined our experience of multivessel PCI to determine the 
factors that limit the effectiveness of PCI in diabetic (DM) patients. 
Methods and Results: Between Jan 2000 and Dee 2001 we performed multivessel PCI 
in 99 DM with 254 treated lesions versus 239 non-DM patients with 620 treated lesions. 
Both groups were well matched as regard clinical and lesions characteristics except that 
DM patients had more renal insufficiency (6.1% vs 0.8%). Number of diseased segments 
treated (2.820.9 vs 2.66iO.79) and stents implanted per patient (2.3iO.6 vs 2.47kO.72) 
were similar in the 2 groups. Angiographic and clinical results after a mean follow up of 
433+275 days were: 
Non-diabetic p value 
Diabetic 
QCA: Reference diameter (mm) 3.17*0.5 3.19+0.6 NS 
Final MLD 3.19iO.68 3.2lkO.6 NS 
Final diameter stenosis (%) 1.26 +8.1 2.1k7.6 NS 
In-hospital DeathflVR 0 0 
to imDact the climcal outcome of diabetic oatients after PCI. 
NS 
In-hospital Ml 7.1 % 3% NS 
In-hospital MACE 7.1 % 3.3 % NS 
Follow-up Death 4 % 3 % NS 
Follow-up Ml 0 % 3 % NS 
Follow-up TVR 29 % 16 % 0.03 
MACE 38 % 23 % 0.04 
The need for TVR was due to disease progression in 57% of DM patients and 26% in non 
DM patients p=O.O2. The event-free survival was 65*0.5% vs 8020.2 at 1 year and 
55+0.6% vs 7lkO.3 at 2 years (p=O.Ol) for DM and non DM respectively. 
Conclusion:The medium and longer term success of multivessel PCI in diabetic 
patients is limited principally by the need for repeat revascularization which are per- 
formed not only for restenosis but also for disease progression. Consequently, even if 
drug eluting stent technology can eliminate restenosis, disease progression will continue 
mg. One patient underwent CABG at follow-up. Protocol mandated angiography was 
done in 48 asymptomatic patients and none had >70% stenosis of LMCA. On multivari- 
ate analysis, independent predictors of restenosls were bifurcation lesion intervention 
(OR 4.2; 95% Cl 2.2.6.8), diabetes (OR 2.4; 95% Cl 1.8-3.2). and reference vessel diam- 
eter ~3.75 mm (OR 3.2; 95% Cl 2.2-4.3). Event free suwival (Ml, revasculaiization, or 
death) was 72% in high-nsk versus 91% in low-risk patients (p=O.Ol). 
COnCluSiOn: The present analysis suggests that ULMCA stenting is a viable optlon wtth 
good long-term outcome, especially in patients with low risk for CABG. With introduction 
of coated stents. stenting of non-biturcation ULMCA lesion may have equal outcome as 
CABG and can be recommended. 
1076-191 Coronary Artery Bypass Graft or Stent to Treat 
Unprotected Left Main Coronary Artery Stenosis: Direct 
Comparison of Revascularization Strategies 
Marco Boccalafte, Niall Mulvihill, Mohamed Loutfi. Emmanuel Salengro, Rossella 
Gottilla, Bruno Farah, Jean Fajadet, Jean Marco, Clinique Pasteur, Toulouse, France 
Background: Coronary artery bypass surgery (CABG) is the treatment of choice for 
patients with significant disease of the left main (LMCA) coronary artery. Recent data has 
confirmed both the safety and efficacy of percutaneous coronary revascularizatlon (PCI) 
and Stent implantation for LMCA disease in selected patients. To date no trial comparing 
CABG vs PCI has included patients with LMCA disease. We have evaluated in hospital 
and mid term outcomes in patients wth significant (>50%) LMCA disease treated either 
by CABG or PCI. 
Methods and Results: Between Jan 2000 and Dee 2001, 187 patients underwent elec- 
tive revascularization for symptomatic LMCA disease: 115 CABG and 72 PCI. PCI and 
CABG patients were well matched in terms of diabetes (10% vs 14%. NS), previous Ml 
(7.5% vs 8%, NS) and mean LVEF (57+14% YS 59tl3%, N.S.). However, the PCI group 
had patients at higher risk, EuroScore was 4.9 vs 2.5, p=O.OOOl. There were more 
females (10.7 vs 6.4 %, p=O.O02), older patients (74+9 vs 66+9, p=O.OOl), more obstrc- 
tive lung disease (19 vs 1.7%, p=O.OOOl) and more renal impairment (5.3% vs 1.6%, 
p=O.O03) in PCI compared to CABG. In hospital events were : 3 deaths (1 PCI, 2 CABG, 
NS). 7 Ml (4 PCI, 3 CABG, NS) 1 TLR (0 PCI, 1 CABG, NS) and 2 strokes ( 0 PCI, 2 
CABG. NS).Total in-hospital event rate was equal in both groups (4.9% vs 4.9%. NS). At 
a mean follow up of 415* 215 days, there were 16 further deaths (10 PCI vs 6 CABG, 
p=O,O6). only 9 were cardiac (5 PCI vs 4 CABG, NS), 2 Ml (1 PCI vs 1 CABG. NS), 16 
TLR (13 PCI YS 3 CABG, p=O.OOl). EuroScore was an univariate predictor of cardiac 
mortality: 5.5+ 2.5 (cardiac death) vs 3.3 t 2.1 (survivors), p=O.OOl. Kaplan-Meier analy- 
sis revealed cardiac death free survival at 1 year of 92+0.3% vs 94 +0.3% (mean + SEE), 
p=NS and MACE (death, MI, TLR) free survival of 6620.5% YS 86+0.4%, log rank 
1076-l 93 Does Lesion Location Have an Impact on Long-Term 
Clinical Outcome After Unprotected Left Main Coronary 
Artery Stenting? 
Marco Boccalatte, Niall T Mukihill, Rossella Gottilla, Mohamed Loutfi, Emmanuel 
Salengro, Bruno Farah, Jean Paul Bounohure, Jean Fajadet. Jean Marco, Unit& de 
Cardiologie Interventionnelle, Clinique Pasteur, Toulouse, France 
Background: Unprotected left main (LM) coronary stenting is now an accepted alterna- 
tive to coronary surgery with excellent immediate and long term outcomes in selected 
patients. However, the impact of the anatomical location of the target stenosis in the LM 
on climcal outcome is unknown. We set out to assess the impact of target lesion location 
on clinical outcome in unprotected LM stenting 
Methods and Results: Between Jan 1994 and Aug 2002 we performed unprotected LM 
stenting on 214 consecutive patients. There were 167 (80%) male patients, mean age 
74* 8 years, 24% diabetic, 12% renal insufficiency, mean LVEF 57* 14%. The anatomi- 
cal location of the target lesion in the LM was: ostial 26%, mid-shaft 21% and distal bifur- 
cation lesions 53%. Initial procedural success was 100%. The in-hospital MACE rate was 
7.7% (7 deaths, 8 Ml and 1 TLR). Follow up on 197 (98%) was completed for a mean of 
23+ 20 months. Total MACE rate during follow up was 31% (38 deaths, 5 Ml and 35 
TLR). There was a significant difference, by Kaplan Meier analysis, in MACE rates at 1 
and 5 years comparing the distal (D) and non-distal (ND) (ostial and mid shaft) lesions: 
61% and 39% for D and 78% and 62% for ND respectively, p<O.OOOl There was an 
increased mortality in the D group: 27% vs 14%, ~~0.03 although cardiac mortality was 
not different 19% vs 1 l%, NS. There was no difference in the calculated Euroscore 
between patients with D and ND lesions: 4.9+2.5 vs 4.7+2 p=NS. There was also a sig- 
nificant difference in the TLR rates beh.veen the 2 groups: 27 vs 8, p=O.O02 for D vs ND 
respectively. 
COnCluSion: Unprotected LM stenting can be performed with excellent lmmedmte and 
long term outcomes in ostial and mid-shaft lesions. Stenting of unprotected distal LM 
lesions is associated with a significantly Increased risk of death and TLR The majomy of 
the events was concentrated in the first 6 months following procedure suggesting an 
important role of in stent restenosis. This issue may be overcome in the near future by 
the use of drug eluting stents. 
